InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,078.67
(
-2.10%
)
Post# of 252502
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 18
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: iwfal post# 137315

Saturday, 02/18/2012 9:12:08 AM

Saturday, February 18, 2012 9:12:08 AM

Post# of 252502
The gccr and gcgr phase 1 trials started in 11/2011:
http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=1624758&highlight=

ISIS does not list healthy volunteer studies on clinicaltrials.gov. They have guided for the phase 1 data to be available this year.

FYI ISIS also terminated their SGLT2 drug.

Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up